OMDA
Omada Health, Inc.
20.90$
+0.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +114.6% | -5.1% | +6.2% | -0.9% | +8.4% | |
| – | – | – | – | – | – | – | +164.4% | -6.0% | +7.1% | -1.3% | +9.5% | |
| – | – | – | – | – | – | – | +275.7% | -11.0% | +11.8% | -4.6% | +4.7% | |
| – | – | – | – | – | – | – | +275.7% | -11.0% | +11.8% | -4.6% | +4.7% | |
| – | – | – | – | – | – | +208.8% | +13.7% | +24.5% | -16.6% | +15.6% | +41.5% | |
| – | – | – | – | – | – | – | +14.0% | -9.3% | +42.5% | -14.6% | +7.5% | |
| – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | -12.5% | -13.3% | -15.4% | -18.2% | -22.2% | |
| – | – | – | – | – | – | -84.6% | +8.0% | -21.0% | +8.0% | -9.3% | +9.9% | |
| – | – | – | – | – | – | – | +17.8% | +20.9% | +8.0% | -9.3% | +9.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +53.7% | -27.8% | +92.3% | -21.2% | +45.7% | |
| – | – | – | – | – | – | – | +0.3% | – | – | – | – | |
| – | – | – | – | – | – | – | +263.2% | +1.5% | +5.7% | +1.9% | +8.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +2.8% | +0.6% | +1.3% | +0.8% | +8.5% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.